Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus

Gerontology

Volumn 56, Issue 2, 2010, Pages 141-149

  Sakurai, Takashi ^a   Iimuro, Satoshi ^b   Araki, Atsushi ^c   Umegaki, Hiroyuki ^d   Ohashi, Yasuo ^b   Yokono, Koichi ^a   Ito, Hideki ^c  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Insulin resistance; Metabolic disease clustering; Obesity; Waist circumference

Indexed keywords

INSULIN;

ABDOMINAL OBESITY; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 77949570040     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000246970     Document Type: Article

References (54)

1. Yaffe K, Kanaya A, Lindquist K, Simonsick E, Harris T, Shorr R, Tylavsky F, Newman A: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242
2. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, Roriz-Filho J, Cruz T, Rodrigues R, Resmini I, Sudoh S, Wakatsuki Y, Nakagawa M, Souza A, Kita T, Matsubayashi K: Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 2007; 55: 374-382
3. Grundy S: What is the contribution of obesity to the metabolic syndrome? Endcrinol Metab Clin North Am 2004; 33: 267-282
4. Eckel R, Grundy S, Zimmet P: The metabolic syndrome. Lancet 2005; 365: 1415-1428
5. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M: HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002; 25: 1135-1141
6. Alexander C, Landsman P, Teutsch S, Haffner S; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP): NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214
7. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004; 21: 52-58
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689
9. Monami M, Marchionni N, Masotti G, Mannucci E: IDF and ATP-III definitions of metabolic syndrome in the prediction of allcause mortality in type 2 diabetic patients. Diabetes Obes Metab 2007; 9: 350-353
10. Tong P, Kong A, So WY, Yang X, Ho C, Ma R, Ozaki R, Chow C, Lam C, Chan J, Cockram C: The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211
11. Metascreen Writing Committee, Bonadonna R, Cucinotta D, Fedele D, Riccardi G, Tiengo A: The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinicbased survey. Diabetes Care 2006; 29: 2701-2707
12. Ko G, So W, Chan N, Chan W, Tong P, Li J, Yeung V, Chow C, Ozaki R, Ma R, Cockram C, Chan J: Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome. Diabetes Obes Metab 2006; 8: 94-104
13. de Simone G, Devereux R, Chinali M, Best L, Lee E, Galloway J, Resnick H; Strong Heart Study Investigators: Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 2007; 30: 1851-1856
14. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol 2007; 6: 13
15. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304
16. Karakelides H, Sreekumaran Nair K: Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 2005; 68: 123-148
17. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H: Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22: 376-384
18. Umegaki H, Iimuro S, Kaneko T, Araki A, Sakurai T, Ohashi Y, Iguchi A, Ito H: Factors associated with lower Mini Mental State Examination scores in elderly Japanese diabetes mellitus patients. Neurobiol Aging 2008; 29: 1022-1026
19. International Diabetes Federation: The IDF consensus worldwide definition of metabolic syndrome [article online], 2005 and 2007 (http://www.idf.org/ webdata/docs/IDF- Meta-def-final.pdf)
20. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T: Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 2006; 13: 202-208
21. Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, Gordon D, Krauss R, Savage P, Smith S Jr, Spertus J, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
22. Matsuzawa Y: Metabolic syndrome - definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301
23. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group: The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062
24. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T: A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 2006; 29: 1123-1124
25. Eguchi M, Tsuchihashi K, Saitoh S, Odawara Y, Hirano T, Nakata T, Miura T, Ura N, Hare yama M, Shimamoto K: Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007; 30: 315-323
26. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamoto S, Asano A, Hagishita T, Mori M, Moriuchi T, Kobayashi M, Katsuda S, Kawashiri MA, Nohara A, Takeda Y, Mabuchi H, Yamagishi M: Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008; 79: 474-481
27. Wallace T, Levy J, Matthews D: Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495
28. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
29. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822
30. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005; 28: 1463-1471
31. De Cosmo S, Minenna A, Ludovico O, Mastroianno S, Di Giorgio A, Pirro L, Trischitta V: Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. Diabetes Care 2005; 28: 910-915
32. Mak K, Ma S, Heng D, Tan C, Tai E, Topol E, Chew S: Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol 2007; 100: 227-233
33. Balkau B, Charles M, Drivsholm T, Borch- Johnsen K, Wareham N, Yudkin J, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B, European Group for the Study of Insulin Resistance: Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376
34. Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436
35. Meigs J, Wilson P, Nathan D, D'Agostino R Sr, Williams K, Haffner S: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-2167
36. Thanopoulou A, Karamanos B, Angelico F, Assaad-Khalil S, Djordjevic P, Katsilambros N, Migdalis I, Mrabet M, Petkova M, Roussi D, Tenconi MT, Archimandritis A: Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. Eur J Clin Nutr 2006; 60: 1376-1383
37. DECODA Study Group: Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 2007; 76: 57-67
38. Athyros V, Ganotakis E, Elisaf M, Liberopoulos E, Goudevenos I, Karagiannis A; GREECE-METS Collaborative Group: Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007; 117: 204-210
39. Lawlor D, Ebrahim S, Smith G: The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study. Diabetic Med 2004; 8: 906-913
40. Morino K, Petersen K, Shulman G: Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006; 55(suppl 2):S9-S15
41. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group: Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-2140
42. Relimpio F, Martinez-Brocca M, Leal-Cerro A, Losada F, Mangas M, Pumar A, Astorga R: Variability in the presence of the metabolic syndrome in type 2 diabetic patients attending a diabetes clinic: influences of age and gender. Diabetes Res Clin Pract 2004; 65: 135-142
43. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P; Casale Monferrato Study: Metabolic syndrome as a predictor of allcause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004; 27: 2689-2694
44. Gimeno Orna J, Lou Arnal L, Molinero Herguedas E, Boned Julián B, Portilla Córdoba D: Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes (in Spanish). Rev Esp Cardiol 2004; 57: 507-513
45. Costa L, Canani L, Lisboa H, Tres G, Gross J: Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 2004; 21: 252-255
46. Lee Y, Tsai J: ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002-1008
47. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study (JDCS) Group: The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care 2006; 29: 145-147
48. Koehler C, Ott P, Benke I, Hanefeld M; DIG Study Group: Comparison of the prevalence of the metabolic syndrome by WHO, AHA/ NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res 2007; 39: 632-635
49. Scuteri A, Najjar S, Morrell C, Lakatta E; Cardiovascular Health Study: The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005; 28: 882-887
50. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan D, Satterfield S, Newman A, Goodpaster B, Bauer D, Holvoet P, Harris T, de Rekeneire N, Rubin S, Ding J, Kritchevsky S; Health ABC Study: Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47: 1595-1602
51. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu F: Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006; 47: 1588-1594
52. Katzmarzyk PT, Janssen I, Ross R, Church T, Blair S: The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404-409
53. Yoon Y, Lee E, Park C, Lee S, Oh S: The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but nonobese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) 2007; 31: 528-534
54. Kadota A, Hozawa A, Okamura T, Kadowak T, Nakmaura K, Murakami Y, Hayakawa T, Kita Y, Okayama A, Nakamura Y, Kashiwagi A, Ueshima H; NIPPON DATA Research Group: Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 2007; 30: 1533-1538